Boryung Pharm Cash Flow Quality Index
Boryung Pharm cash flow quality index. Boryung Pharm (003850) has a Cash Flow Quality Index of 1.44x as of September 2025. Operating cash flow of ₩48.95 Billion exceeds net income of ₩34.00 Billion, indicating high earnings quality where cash backs reported profits. See Boryung Pharm (003850) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Boryung Pharm (2009–2024)
Cash flow quality index of Boryung Pharm from 2009 to 2024. Historical Cash Flow Quality Index for Boryung Pharm across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Boryung Pharm to assess how comfortably operating cash covers total debt obligations.
Boryung Pharm Cash Flow Quality Index by Year (2009–2024)
Boryung Pharm cash flow quality index by year from 2009 to 2024. Year-by-year earnings quality comparison for Boryung Pharm. For the full cash flow conversion analysis, see how efficiently does Boryung Pharm generate cash.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.11x | ₩80.56 Billion | ₩72.77 Billion | ▲ +5.4% |
| 2023 | 1.05x | ₩42.22 Billion | ₩40.20 Billion | ▲ +54.5% |
| 2022 | 0.68x | ₩27.81 Billion | ₩40.92 Billion | ▼ -51.4% |
| 2021 | 1.40x | ₩60.17 Billion | ₩43.04 Billion | ▼ -16.1% |
| 2020 | 1.67x | ₩44.74 Billion | ₩26.86 Billion | ▲ +14.2% |
| 2019 | 1.46x | ₩47.00 Billion | ₩32.22 Billion | ▼ -23.9% |
| 2018 | 1.92x | ₩38.91 Billion | ₩20.31 Billion | ▲ +541.4% |
| 2017 | -0.43x | ₩-24.61 Billion | ₩56.70 Billion | ▼ -126.0% |
| 2016 | 1.67x | ₩9.36 Billion | ₩5.61 Billion | ▼ -14.7% |
| 2012 | 1.95x | ₩18.38 Billion | ₩9.40 Billion | ▲ +31.5% |
| 2011 | 1.49x | ₩9.19 Billion | ₩6.18 Billion | ▼ -11.5% |
| 2010 | 1.68x | ₩24.12 Billion | ₩14.35 Billion | ▲ +142.4% |
| 2009 | 0.69x | ₩3.59 Billion | ₩5.18 Billion | — |